Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
McKesson
Harvard Business School
Chubb
Cantor Fitzgerald
Covington
US Department of Justice
Argus Health
Dow

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,384,310

« Back to Dashboard

Summary for Patent: 5,384,310
Title: 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions
Abstract:The present invention is directed to certain 2'-fluoro, 2-substituted purine nucleosides which are toxic to cancerous cell lines.
Inventor(s): Montgomery; John A. (Birmingham, AL), Secrist, III; John A. (Birmingham, AL)
Assignee: Southern Research Institute (Birmingham, AL)
Application Number:07/693,646
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;

Drugs Protected by US Patent 5,384,310

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,384,310

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 69029733 ➤ Subscribe
Germany 122006000060 ➤ Subscribe
European Patent Office 0473708 ➤ Subscribe 300247 Netherlands ➤ Subscribe
European Patent Office 0473708 ➤ Subscribe 06C0038 France ➤ Subscribe
European Patent Office 0473708 ➤ Subscribe SPC/GB06/040 United Kingdom ➤ Subscribe
Canada 2102782 ➤ Subscribe
European Patent Office 0595826 ➤ Subscribe
Australia 5831590 ➤ Subscribe
Austria 147751 ➤ Subscribe
Spain 2098266 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Fuji
Cipla
Fish and Richardson
Boehringer Ingelheim
US Army
US Department of Justice
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot